Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 51(3): e5612, 2018. graf
Artículo en Inglés | LILACS | ID: biblio-889034

RESUMEN

Breast cancer is the most common cause of cancer among women in most countries (WHO). Ovarian hormone disorder is thought to be associated with breast tumorigenesis. The present study investigated the effects of estrogen and progesterone administration on cell proliferation and underlying mechanisms in breast cancer MCF-7 cells. It was found that a single administration of estradiol (E2) or progesterone increased MCF-7 cell viability in a dose-dependent manner and promoted cell cycle progression by increasing the percentage of cells in the G2/M phase. A combination of E2 and progesterone led to a stronger effect than single treatment. Moreover, cyclin G1 was up-regulated by E2 and/or progesterone in MCF-7 cells. After knockdown of cyclin G1 in MCF-7 cells using a specific shRNA, estradiol- and progesterone-mediated cell viability and clonogenic ability were significantly limited. Additionally, estradiol- and progesterone-promoted cell accumulation in the G2/M phase was reversed after knockdown of cyclin G1. These data indicated that estrogen and progesterone promoted breast cancer cell proliferation by inducing the expression of cyclin G1. Our data indicated that novel therapeutics against cyclin G1 are promising for the treatment of estrogen- and progesterone-mediated breast cancer progression.


Asunto(s)
Humanos , Femenino , Progesterona/farmacología , Neoplasias de la Mama/patología , Proliferación Celular/efectos de los fármacos , Estrógenos/farmacología , Ciclina G1/metabolismo , Neoplasias de la Mama/metabolismo , Supervivencia Celular , Western Blotting , Reacción en Cadena en Tiempo Real de la Polimerasa , Células MCF-7/efectos de los fármacos
2.
Braz. j. med. biol. res ; 46(8): 681-688, ago. 2013. tab, graf
Artículo en Inglés | LILACS | ID: lil-684528

RESUMEN

Hepatic oval cells (HOCs) are recognized as facultative liver progenitor cells that play a role in liver regeneration after acute liver injury. Here, we investigated the in vitro proliferation and differentiation characteristics of HOCs in order to explore their potential capacity for intrahepatic transplantation. Clusters or scattered HOCs were detected in the portal area and interlobular bile duct in the liver of rats subjected to the modified 2-acetylaminofluorene and partial hepatectomy method. Isolated HOCs were positive for c-kit and CD90 staining (99.8% and 88.8%, respectively), and negative for CD34 staining (3.6%) as shown by immunostaining and flow cytometric analysis. In addition, HOCs could be differentiated into hepatocytes and bile duct epithelial cells after leukemia inhibitory factor deprivation. A two-cuff technique was used for orthotopic liver transplantation, and HOCs were subsequently transplanted into recipients. Biochemical indicators of liver function were assessed 4 weeks after transplantation. HOC transplantation significantly prolonged the median survival time and improved the liver function of rats receiving HOCs compared to controls (P=0.003, Student t-test). Administration of HOCs to rats also receiving liver transplantation significantly reduced acute allograft rejection compared to control liver transplant rats 3 weeks following transplantation (rejection activity index score: control=6.3±0.9; HOC=3.5±1.5; P=0.005). These results indicate that HOCs may be useful in therapeutic liver regeneration after orthotopic liver transplantation.


Asunto(s)
Animales , Femenino , Masculino , Ratas , Proliferación Celular , Diferenciación Celular/fisiología , Trasplante de Células/métodos , Hepatocitos/citología , Trasplante de Hígado/métodos , Citometría de Flujo , Rechazo de Injerto/diagnóstico , Hepatectomía , Inmunohistoquímica , Hígado/anatomía & histología , Hígado/cirugía , Cultivo Primario de Células , Ratas Endogámicas Lew , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA